Post-approval studies (Phase 4)UnknownNCT00216229What this trial is testingTwinrix Alternative Schedule StudyWho this might be right forAntibody Response After Vaccination IDEWE Occupational Health Services 400
Early research (Phase 1)Study completedNCT03895385What this trial is testingEvaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy SubjectsWho this might be right forHealthy Volunteers UCB Biopharma S.P.R.L. 56
Testing effectiveness (Phase 2)Study completedNCT05074303What this trial is testingBeta-glucan and Immune Response to Influenza VaccineWho this might be right forHealthy Aging University of Florida 78
Post-approval studies (Phase 4)Study completedNCT00964769What this trial is testingStudy of Evaluation Indexes for Antibody Production in Sera After ImmunizationWho this might be right forAged Ewha Womans University 70
Not applicableUnknownNCT05175989What this trial is testingSARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19Who this might be right forCOVID-19 Vaccine Rabin Medical Center 150
Not applicableStudy completedNCT00889278What this trial is testingHigher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell TransplantationWho this might be right forLymphoma Dartmouth-Hitchcock Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT02946385What this trial is testingStudy to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in AdolescentsWho this might be right forInfections, Meningococcal GlaxoSmithKline 604
Post-approval studies (Phase 4)Study completedNCT03294135What this trial is testingThe Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults VaccineWho this might be right forVirus Diseases GlaxoSmithKline 194
Post-approval studies (Phase 4)Study completedNCT01823536What this trial is testingPersistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster DoseWho this might be right forMeningococcal Disease Novartis Vaccines 465
Large-scale testing (Phase 3)Study completedNCT01026038What this trial is testingStudy Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.Who this might be right for13-valent Pneumococcal VaccineImmunizationSafety+1 more Pfizer 263
Testing effectiveness (Phase 2)Study completedNCT01097096What this trial is testingSafety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsWho this might be right forAlzheimer's Disease Novartis Pharmaceuticals 177
Not applicableStudy completedNCT04922944What this trial is testingPost COVID-19 Vaccination Analysis in Healthcare Worker RecipientsWho this might be right forCovid19Vaccine Reaction Huntington Memorial Hospital 167
Not applicableStudy completedNCT00962819What this trial is testingMeasles, Mumps, and Rubella (MMR) Immunity in College StudentsWho this might be right forMeaslesMumpsRubella Sri Edupuganti, MD MPH 74
Not applicableStudy completedNCT04844489What this trial is testingStudy of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleWho this might be right forAutoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more Assistance Publique - Hôpitaux de Paris 377
Testing effectiveness (Phase 2)Study completedNCT05077254What this trial is testingCOVID Protection After Transplant-Immunosuppression ReductionWho this might be right forKidney Transplant RecipientsLiver Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT01012557What this trial is testingH1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant WomenWho this might be right forH1N1v Influenza Copenhagen Studies on Asthma in Childhood 296
Not applicableUnknownNCT04779996What this trial is testingAntibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 TreatmentWho this might be right forCovid19CancerHIV Infections Auxilio Mutuo Cancer Center 250
Not applicableStudy completedNCT01254955What this trial is testingAntibody Production Following H1N1 Influenza Vaccination in Organ Transplant PatientsWho this might be right forOrgan Transplantation Sahlgrenska University Hospital
Post-approval studies (Phase 4)Study completedNCT00894686What this trial is testingTick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)Who this might be right forEncephalitis, Tick-Borne Pfizer 179
Post-approval studies (Phase 4)Study completedNCT00240500What this trial is testingFollow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ MothersWho this might be right forHepatitis B GlaxoSmithKline 109